Toxicity of pyroglutaminated amyloid β-peptides 3(pE)-40 and-42 is similar to that of Aβ1-40 and-42

被引:45
|
作者
Tekirian, TL
Yang, AY
Glabe, C
Geddes, JW
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA
关键词
Alzheimer's disease; amyloid beta-peptide; circular dichroism; neurotoxins; peptide fragments;
D O I
10.1046/j.1471-4159.1999.0731584.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An N-terminal truncated isoform of the amyloid beta-peptide (A beta) that begins with a pyroglutamate (pE) residue at position 3 [A beta 3(pE)-42] is the predominant isoform found in senile plaques. Based upon previous in vitro studies regarding A beta N-terminal truncated isoforms, it has been hypothesized that A beta S(pE)-x isoforms may aggregate more rapidly and become more toxic than corresponding A beta 1-x peptides, However, the toxicity and aggregation properties of A beta 3(pE)-42 and A beta 3(pE)-40 have not previously been examined. After initial solubilization and 1-week preaggregation of each peptide at 37 degrees C and pH 7.4, the toxicity of 5-50 mu M A beta 3(pE)-42 was similar to that of A beta 1-42. Moreover, the toxicity of A beta 3(pE)-40 paralleled that induced by A beta 1-40 in both 1 day in vitro (DIV) cortical and 7 DIV hippocampal cells. Circular dichroism spectra did not reveal major differences in secondary structure between aged A beta 1-42, A beta 3(pE)-42, A beta 3(pE)-40, and A beta 1-40 or freshly solubilized forms of these peptides. Overall, the data indicate that the loss of the two N-terminal amino acids and the cyclization of glutamate at position 3 do not alter the extracellular toxicity of A beta.
引用
收藏
页码:1584 / 1589
页数:6
相关论文
共 50 条
  • [41] Cu2+ accentuates distinct misfolding of Aβ(1-40) and Aβ(1-42) peptides, and potentiates membrane disruption
    Matheou, Christian J.
    Younan, Nadine D.
    Viles, John H.
    BIOCHEMICAL JOURNAL, 2015, 466 : 233 - 242
  • [42] Predicting the in vitro toxicity of synthetic beta-amyloid (1-40)
    Brining, SK
    NEUROBIOLOGY OF AGING, 1997, 18 (06) : 581 - 589
  • [43] Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides
    Arispe, N
    Doh, M
    FASEB JOURNAL, 2002, 16 (12) : 1526 - 1536
  • [44] Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1-42) compared to Aβ(1-40)
    Wesen, Emelie
    Jeffries, Gavin D. M.
    Dzebo, Maria Matson
    Esbjorner, Elin K.
    SCIENTIFIC REPORTS, 2017, 7
  • [45] An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF
    DeMarco, Mari L.
    Quyen Nguyen
    Fok, Alice
    Hsiung, Ging-Yuek Robin
    van der Gugten, J. Grace
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [46] Amyloid-β1-40 Inhibits Amyloid-β1-42 Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Degeneration
    Bate, Clive
    Williams, Alun
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 985 - 993
  • [47] Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
    Verberk, Inge M. W.
    Thijssen, Elisabeth
    Koelewijn, Jannet
    Mauroo, Kimberley
    Vanbrabant, Jeroen
    de Wilde, Arno
    Zwan, Marissa D.
    Verfaillie, Sander C. J.
    Ossenkoppele, Rik
    Barkhof, Frederik
    van Berckel, Bart N. M.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Stoops, Erik
    Vanderstichele, Hugo M.
    Teunissen, Charlotte E.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [48] Amide solvent protection analysis demonstrates that amyloid-β(1-40) and amyloid-β(1-42) form different fibrillar structures under identical conditions
    Olofsson, Anders
    Lindhagen-Persson, Malin
    Sauer-Eriksson, A. Elisabeth
    Ohman, Anders
    BIOCHEMICAL JOURNAL, 2007, 404 (01) : 63 - 70
  • [49] Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
    Andreasson, Ulf
    Kuhlmann, Julia
    Pannee, Josef
    Umek, Robert M.
    Stoops, Erik
    Vanderstichele, Hugo
    Matzen, Anja
    Vandijck, Manu
    Dauwe, Martine
    Leinenbach, Andreas
    Rutz, Sandra
    Portelius, Erik
    Zegers, Ingrid
    Zetterberg, Henrik
    Blennow, Kaj
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (12) : 2058 - 2066
  • [50] Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
    Liu, Huei-Chun
    Chiu, Ming-Jang
    Lin, Chin-Hsien
    Yang, Shieh-Yueh
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2020, 10 (01) : 46 - 55